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ABSTRACT   We examined whether or not acute upper respiratory tract infection is 
associated with Q fever (Coxiella burnetii infection). The subjects consisted of 124 patients 
with acute upper respiratory tract infection. At initial medical consultation, the presence or 
absence of serum C. burnetii was examined by nested PCR method. Of the 124 patients, no 
patients (0 percent) were positive for C. burnetii in serum. These results suggested that the 
involvement of Q fever in acute upper respiratory tract infection is extremely low.
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〈Regular Article〉
INTRODUCTION
   Q fever is zoonosis caused by infection of Coxiella 
burnetii. Pets such as dogs or cats, domestic 
livestock such as cows, goats, or sheep, and various 
wild animals are sources for human infection. In 
infected animals, C. burnetii is reactivated during 
pregnancy and rapidly grows in the placenta. When 
infected animals deliver their offspring, C. burnetii 
spreads and in humans causes infection following 
its inhalation.  Patients develop atypical pneumonia 
and chronic fatigue syndrome occur by chronic 
persistent infection. In this study, the involvement 
of Q fever in acute upper respiratory tract infection 
was examined.
SUBJECTS AND METHODS
Subjects
   We examined 124 patients (64 males and 60 
females, age; 18-75 years old; mean 42) with acute 
upper respiratory tract infection treated as outpatient 
at Kawasaki Hospital, Kawasaki Medical School 
from April 1, 2014 to December 31, 2015.
   Acute upper respiratory tract infection was defined 
as development of fever 37.5℃ or greater and cold 
symptoms such as pharyngeal pain, headache, nasal 
discharge, cough, or sputum.
   The underlying diseases of subjects were chronic 
obstructive pulmonary disease in 20 patients, 
hypertension in 18 patients, diabetes mellitus 10 
patients, bronchiectasis in 8 patients, lung cancer in 
8 patients, M. avium cmplex in 7 patients, idiopathic 
interstitial pneumonias in 5 patients, other disease in 
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20 patients and none in 28 patients.
   The physical status of subjects were PS 1 in 101 
patients and PS 2 in 23 patients.
Methods
   At initial medical consultation, the presence of 
serum C. burnetii was examined by nested PCR 
method１）. The primers of this nested PCR was the 
com1 gene encoding a 27-kDa outer membrane 
protein of C. burnetii. Positive results of nested PCR 
were correlated with the serum antibody titers of C. 
burnetii.
   This study was conducted after obtaining 
permission from the ethical committee of our 
institution.
RESULTS
   Of the 124 patients, no patients (0 percent) were 
positive for C. burnetii in serum (Table 1).
DISCUSSION
   We have reported the involvement of Q fever in 
4 (1.4 percent) of 284 patients with community-
acquired pneumonia２）, 6 (6.7 percent) of 89 
patients with acute exacerbation of bronchial 
asthma３）, 2 (2.5 percent) of 80 patients with acute 
exacerbations/infections in chronic lung disease４）, 
0 (0 percent) of 121 patients with hospital-acquired 
pneumonia５）, and 1 (1.1 percent) of 94 patients 
with prolonged cough６）. In this study we examined 
the involvement of Q fever in 124 patients with 
acute upper respiratory tract infection, and found no 
patients with C. burnetii.
  In 1993 Nagaoka et al.７） reported first isolation 
of the Q fever agent from patients with influenza-
like illness in Japan, and Takahashi et al.８） reported 
that 2 (1.3 percent) of 149 patients with acute upper 
respiratory tract infection had Q fever. In Greece, 
Pappas et al.９） reported 2 patients with acute upper 
respiratory tract infection. While serum antibody 
value was used for diagnosis in these reports, we 
employed nested PCR method with serum in the 
present study. The absence of positive patients may 
be due to the lower amount of C. burnetii  in serum 
in acute upper respiratory tract infection.
   Furthermore, we would like to examine nasal or 
throat swab as specimens.
  Considering the results of this study and past 
reports, it was concluded that the involvement of 
Q fever in acute upper respiratory tract infection is 
extremely low.
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